The estimated Net Worth of Elias A. Zerhouni is at least $11.6 Milion dollars as of 15 July 2024. Elias Zerhouni owns over 3,289 units of Danaher stock worth over $10,194,626 and over the last 14 years he sold DHR stock worth over $1,119,584. In addition, he makes $335,078 as Independent Director at Danaher.
Sign up
Elias Zerhouni DHR stock SEC Form 4 insiders trading
Elias has made over 8 trades of the Danaher stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 3,289 units of DHR stock worth $172,870 on 15 July 2024.
The largest trade he's ever made was buying 550,300 units of Danaher stock on 5 January 2024 worth over $511,779. On average, Elias trades about 8,799 units every 61 days since 2010. As of 15 July 2024 he still owns at least 37,483 units of Danaher stock.
You can see the complete history of Elias Zerhouni stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Elias Zerhouni biography
Dr. Elias A. Zerhouni M.D. serves as Independent Director of the Company. Dr. Zerhouni served as President, Global Research & Development, for Sanofi S.A., a global pharmaceutical company, from 2011 to June 2018. From 2008 until 2011, he provided advisory and consulting services to various non-profit and other organizations as Chairman and President of Zerhouni Holdings. From 2002 to 2008, Dr. Zerhouni served as director of the National Institutes of Health, and from 1996 to 2002, he served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the Johns Hopkins School of Medicine.
What is the salary of Elias Zerhouni?
As the Independent Director of Danaher, the total compensation of Elias Zerhouni at Danaher is $335,078. There are 12 executives at Danaher getting paid more, with Rainer Blair having the highest compensation of $7,178,650.
How old is Elias Zerhouni?
Elias Zerhouni is 68, he's been the Independent Director of Danaher since 2009. There are 4 older and 22 younger executives at Danaher. The oldest executive at Danaher Corp. is John Schwieters, 80, who is the Independent Director.
What's Elias Zerhouni's mailing address?
Elias's mailing address filed with the SEC is 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON, DC, 20037.
Insiders trading at Danaher
Over the last 20 years, insiders at Danaher have traded over $2,183,160,204 worth of Danaher stock and bought 226,618 units worth $34,863,916 . The most active insiders traders include Steven M Rales, Mitchell P Rales oraz Robert J Hugin. On average, Danaher executives and independent directors trade stock every 14 days with the average trade being worth of $25,840,276. The most recent stock trade was executed by Georgeann Couchara on 26 August 2024, trading 952 units of DHR stock currently worth $255,488.
What does Danaher do?
Danaher Corporation is an American globally diversified conglomerate founded by brothers Stephen and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.
What does Danaher's logo look like?
Complete history of Elias Zerhouni stock trades at Opko Health Inc i Danaher
Danaher executives and stock owners
Danaher executives and other stock owners filed with the SEC include:
-
Rainer Blair,
President, Chief Executive Officer, Director -
Daniel Comas,
Executive Vice President -
Joakim Weidemanis,
Executive Vice President -
Matthew McGrew,
Chief Financial Officer, Executive Vice President -
Angela Lalor,
Senior Vice President - Human Resources -
Rainer M. Blair,
Pres, CEO & Director -
Brian Ellis,
Senior Vice President, Chief Compliance Officer, General Counsel -
Angela S. Lalor,
Sr. VP of HR -
Joakim Weidemanis,
Exec. VP -
Matthew R. McGrew,
CFO & Exec. VP -
Brian W. Ellis,
Sr. VP, Gen. Counsel & Chief Compliance Officer -
John Schwieters,
Independent Director -
Elias Zerhouni,
Independent Director -
Linda Hefner Filler,
Lead Independent Director -
Walter Lohr,
Independent Director -
Raymond Stevens,
Independent Director -
Alan Spoon,
Independent Director -
Teri List-Stoll,
Independent Director -
Pardis Sabeti,
Independent Director -
Jessica Mega,
Independent Director -
Mitchell P. Rales,
Co-Founder & Director -
Steven M. Rales,
Co-Founder & Chairman -
Mitchell Rales,
Director -
Daniel Raskas,
Senior Vice President - Corporate Development -
William King,
Senior Vice President - Strategic Development -
Robert Lutz,
Senior Vice President, Chief Accounting Officer -
Steven Rales,
Chairman of the Board -
Matthew E. Gugino C.F.A., CPA,
VP of Investor Relations and FP&A -
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.,
Sr. VP & Chief Science Officer -
Christopher M. Bouda,
Chief Accounting Officer -
Teri List,
Director -
Robert J Hugin,
Director -
Donald J Ehrlich,
Director -
William K Daniel,
EVP -
Thomas Patrick Jr Joyce,
President and CEO -
Christopher Paul Riley,
Executive Vice President -
Jonathan P Graham,
Senior VP & GC -
Montgomery Julie A Sawyer,
Executive Vice President -
H Lawrence Jr Culp,
President and CEO -
Philip Knisely,
Executive Vice President -
Mortimer M Caplin,
Director -
A Emmet Jr Stephenson,
Director -
James H Ditkoff,
Senior VP-Tax & Finance -
Steve Simms,
Executive Vice President -
Patrick W Allender,
Executive VP -
Daniel A Pryor,
VP-Strategic Development -
Mark A Beck,
Executive Vice President -
James A Lico,
Executive Vice President -
Georgeann Couchara,
SVP, Human Resources -
Feroz Dewan,
Director -
Jennifer Honeycutt,
Executive Vice President -
A Shane Sanders,
Director -
Christopher Bouda,
VP, Chief Accounting Officer -
Jose Carlos Gutierrez Ramos,
SVP, Chief Science Officer